Primary Study Endpoints The primary study endpoint is to measure CTC levels and MTF levels and compare these against known biomarkers expressed in pancreatic cancer.
Secondary Study Endpoints The secondary study endpoints are to determine if novel markers are useful for the detection of CTCs and MTFs and whether levels of CTCs and MTFs correlate with therapeutic efficacy, as well as whether MTF marker expression patterns reflect response to therapeutic interventions.
